CD8A and neoplasm: Similar to in vitro experiments, in vivo inhibition of the JAK/STAT pathway led to reduced tumor growth in mice, decreased Ki-67-positive cells, and increased expression of granzyme in CD8+ cells in the tumor microenvironment.